Intraoperative blood salvage may shorten the lifespan of red blood cells within 3 days postoperatively

Medicine (United States)

Volumn 96, Issue 39, 2017, Pages

  Liao, Xin Yi ^a   Zuo, Shan Shan ^b   Meng, Wen Tong ^c   Zhang, Jie ^d   Huang, Qin ^e   Gou, Da Ming ^a  

^a ZUNYI MEDICAL UNIVERSITY   (China)

^b Zhengzhou Central Hospital   (China)

^c SICHUAN UNIVERSITY   (China)

^d SICHUAN UNIVERSITY   (China)

^e Hospital of Honghuagang District   (China)

Author keywords

intraoperative blood salvage; RBC lifespan; RBC engulfing granulocyte

Indexed keywords

HEMOGLOBIN;

ADULT; ARTICLE; BLOOD CELL COUNT; BLOOD SALVAGE; BLOOD VOLUME; CELL VOLUME; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; LIFESPAN; MALE; MIDDLE AGED; OPERATIVE BLOOD LOSS; ORTHOPEDIC SURGERY; PELVIS SURGERY; PEROPERATIVE CARE; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SPINE SURGERY; ADVERSE EFFECTS; ANEMIA; BLOOD AUTOTRANSFUSION; BLOOD LOSS, SURGICAL; CELL SURVIVAL; ERYTHROCYTE COUNT; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; PROCEDURES; RISK ASSESSMENT; STATISTICS; TREATMENT OUTCOME;

ADULT; ANEMIA; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION, AUTOLOGOUS; BLOOD VOLUME; CELL SURVIVAL; ERYTHROCYTE COUNT; ERYTHROCYTES; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; OPERATIVE BLOOD SALVAGE; ORTHOPEDIC PROCEDURES; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STATISTICS AS TOPIC;

EID: 85030761475     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000008143     Document Type: Article

References (17)

1. Walsh TS, Palmer J, Watson D, et al. Multicentre cohort study of red blood cell use for revision hip arthroplasty and factors associated with greater risk of allogeneic blood transfusion. Br J Anaesth 2012;108: 63-71.
2. Weltert L, Nardella S, Rondinelli MB, et al. Reduction of allogeneic red blood cell usage during cardiac surgery by an integrated intra-and postoperative blood salvage strategy: results of a randomized comparison. Transfusion 2013;53:790-7.
3. Wong JC, Torella F, Haynes SL, et al. Autologous versus allogeneic transfusion in aortic surgery: a multicenter randomized clinical trial. Ann Surg 2002;235:145-51.
4. Vermeijden WJ, van Klarenbosch J, Gu YJ, et al. Effects of cell-saving devices and filters on transfusion in cardiac surgery: a multicenter randomized study. Ann Thorac Surg 2015;99:26-32.
5. Cip J,Widemschek M, Benesch T, et al. Does single use of an autologous transfusion system in TKA reduce the need for allogenic blood? A prospective randomized trial. Clin Orthop Relat Res 2013;471: 1319-25.
6. So-Osman C, Nelissen RG, Koopman-van Gemert AW, et al. Patient blood management in elective total hip-and knee-replacement surgery (part 1): a randomized controlled trial on erythropoietin and blood salvage as transfusion alternatives using a restrictive transfusion policy in erythropoietin-eligible patients. Anesthesiology 2014;120:839-51.
7. So-Osman C, Nelissen RG, Koopman-van Gemert AW, et al. Patient blood management in elective total hip-and knee-replacement surgery (part 2): a randomized controlled trial on blood salvage as transfusion alternative using a restrictive transfusion policy in patients with a preoperative hemoglobin above 13g/dl. Anesthesiology 2014;120: 852-60.
8. Gu YJ, Vermeijden WJ, de Vries AJ, et al. Influence of mechanical cell salvage on red blood cell aggregation, deformability, and 2, 3-diphosphoglycerate in patients undergoing cardiac surgery with cardiopulmonary bypass. Ann Thorac Surg 2008;86:1570-5.
9. Yang P, Zhou J, Kang Y, et al. Mannitol-adenine-phosphate: a novel solution for intraoperative blood salvage. Transfusion 2014;54: 1146-52.
10. Lang KS, Lang PA, Bauer C, et al. Mechanisms of suicidal erythrocyte death. Cell Physiol Biochem 2005;15:195-202.
11. Boas FE, Forman L, Beutler E. Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia. ProcNatl Acad Sci U S A 1998;95:3077-81.
12. Voorn VM, Marang-van de Mheen PJ, Wentink MM, et al. Perceived barriers among physicians for stopping non-cost-effective blood-saving measures in total hip and total knee arthroplasties. Transfusion 2014; 54:2598-607.
13. Mock DM, Matthews NI, Zhu S, et al. Red blood cell (RBC) survival determined in humans using RBCs labeled at multiplebiotin densities. Transfusion 2011;51:1047-57.
14. International Committee for Standardization in HaematologyRecommended methods for radioisotope red-cell survival studies. Br J Haematol 1980;45:659-66.
15. Tripkovic B, Sakic K, Jakovina S, et al. Hemolysis and survival of autologous red blood cells salvaged after cemented and uncemented total hip arthroplasty. Am J Orthop (Belle Mead NJ) 2010;39:76-9.
16. Sebastián C, Romero R, Olalla E, et al. Postoperative blood salvage and reinfusion in spinal surgery: blood quality, effectiveness and impact on patient blood parameters. Eur Spine J 2000;9:458-65.
17. Wang X, Ji B, Zhang Y, et al. Comparison of the effects of three cell saver devices on erythrocyte function during cardiopulmonary bypass procedure: a pilot study. Artif Organs 2012;36:931-5.